Rick A. Hillstead

Georgia Venture Partners LLC(Georgia Venture Partners) is an Independent Venture Capital firm founded in 2004 by John P. Richard and Thomas H. Callaway. The firm is headquartered in Atlanta.

Biofisica, Inc. is a world leader in using innovative technology to treat hard-to-heal wounds. At Biofisica, they understand the lives of patients and the needs of the clinicians who manage them. The firm is to develop, manufacture and supply medical devices that trigger the healing process in wounds that fail to heal on their own. These exclusive devices use bio-electric stimulation therapy (bio-current) to restore the conditions which promote natural healing. Founded in 2000, the company headquarters are in Georgia, USA, and its European office is in Hampshire, England. At present their unique devices are available for commercial sale in the European Union, with arrangements being made for launches further a field.

Biofisica, Inc. is a world leader in using innovative technology to treat hard-to-heal wounds. At Biofisica, they understand the lives of patients and the needs of the clinicians who manage them. The firm is to develop, manufacture and supply medical devices that trigger the healing process in wounds that fail to heal on their own. These exclusive devices use bio-electric stimulation therapy (bio-current) to restore the conditions which promote natural healing. Founded in 2000, the company headquarters are in Georgia, USA, and its European office is in Hampshire, England. At present their unique devices are available for commercial sale in the European Union, with arrangements being made for launches further a field.

Georgia Venture Partners LLC(Georgia Venture Partners) is an Independent Venture Capital firm founded in 2004 by John P. Richard and Thomas H. Callaway. The firm is headquartered in Atlanta.

Biofisica, Inc. is a world leader in using innovative technology to treat hard-to-heal wounds. At Biofisica, they understand the lives of patients and the needs of the clinicians who manage them. The firm is to develop, manufacture and supply medical devices that trigger the healing process in wounds that fail to heal on their own. These exclusive devices use bio-electric stimulation therapy (bio-current) to restore the conditions which promote natural healing. Founded in 2000, the company headquarters are in Georgia, USA, and its European office is in Hampshire, England. At present their unique devices are available for commercial sale in the European Union, with arrangements being made for launches further a field.

Biofisica, Inc. is a world leader in using innovative technology to treat hard-to-heal wounds. At Biofisica, they understand the lives of patients and the needs of the clinicians who manage them. The firm is to develop, manufacture and supply medical devices that trigger the healing process in wounds that fail to heal on their own. These exclusive devices use bio-electric stimulation therapy (bio-current) to restore the conditions which promote natural healing. Founded in 2000, the company headquarters are in Georgia, USA, and its European office is in Hampshire, England. At present their unique devices are available for commercial sale in the European Union, with arrangements being made for launches further a field.

Georgia Venture Partners LLC(Georgia Venture Partners) is an Independent Venture Capital firm founded in 2004 by John P. Richard and Thomas H. Callaway. The firm is headquartered in Atlanta.

Biofisica, Inc. is a world leader in using innovative technology to treat hard-to-heal wounds. At Biofisica, they understand the lives of patients and the needs of the clinicians who manage them. The firm is to develop, manufacture and supply medical devices that trigger the healing process in wounds that fail to heal on their own. These exclusive devices use bio-electric stimulation therapy (bio-current) to restore the conditions which promote natural healing. Founded in 2000, the company headquarters are in Georgia, USA, and its European office is in Hampshire, England. At present their unique devices are available for commercial sale in the European Union, with arrangements being made for launches further a field.